Verition Fund Management’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,050	Closed	-$52K	–	2677
2025 Q4	$52K	Hold	14,050	–	–	﹤0.01%	3379
2025 Q3	$37.2K	Hold	14,050	–	–	﹤0.01%	3669
2025 Q2	$13.8K	Sell	14,050 -16,460	-54%	-$16.5K	﹤0.01%	3575
2025 Q1	$43.9K	Buy	30,510 +16,460	+117%	+$30.3K	﹤0.01%	3204
2024 Q4	$30.9K	Hold	14,050	–	–	﹤0.01%	3151
2024 Q3	$23.2K	Hold	14,050	–	–	﹤0.01%	3068
2024 Q2	$31.2K	Hold	14,050	–	–	﹤0.01%	2836
2024 Q1	$37.7K	Hold	14,050	–	–	﹤0.01%	2651
2023 Q4	$42K	Sell	14,050 -75,000	-84%	-$97.3K	﹤0.01%	2186
2023 Q3	$87.3K	Sell	89,050 -61,645	-41%	-$89.2K	﹤0.01%	2134
2023 Q2	$209K	Buy	150,695 +96,289	+177%	+$134K	﹤0.01%	1823
2023 Q1	$86.5K	Buy	54,406 +39,156	+257%	+$202K	﹤0.01%	1923
2022 Q4	$95K	Sell	15,250 -18,670	-55%	-$134K	﹤0.01%	1852
2022 Q3	$227K	Buy	33,920 +17,120	+102%	+$118K	﹤0.01%	2420
2022 Q2	$107K	Buy	+16,800	New	+$95.3K	﹤0.01%	2065
2019 Q3	–	Sell	-4,833	Closed	-$225K	–	1140
2019 Q2	$225K	Buy	+4,833	New	+$227K	0.01%	940